TMHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Taylor Morrison Home Corp (TMHC) is not a strong buy for a beginner, long-term investor at this time. The stock shows technical weakness, declining financial performance, and mixed analyst sentiment. While there are some positive catalysts, the overall data suggests holding off on buying until clearer growth trends or stronger signals emerge.
The stock is currently oversold with an RSI of 15.563, indicating potential for a short-term bounce. However, the MACD is negatively expanding (-0.772), signaling bearish momentum. The stock is trading near its S1 support level of 61.036, with resistance at 64.218. Converging moving averages suggest indecision in price direction.
Truist initiated coverage with a Buy rating and an $85 price target, citing long-term growth potential.
RBC Capital raised the price target to $68, highlighting better-than-normal seasonal performance.
Citizens analyst sees valuation discount as unwarranted, with a $95 price target.
Financial performance in Q4 2025 showed significant declines in revenue (-10.90% YoY), net income (-28.23% YoY), and EPS (-23.48% YoY).
Barclays and RBC Capital analysts remain cautious about housing affordability and market volatility.
The options market reflects bearish sentiment with a high put-call volume ratio.
In Q4 2025, revenue dropped to $2.1 billion (-10.90% YoY), net income fell to $174 million (-28.23% YoY), and EPS declined to 1.76 (-23.48% YoY). Gross margin also decreased to 22.04% (-8.36% YoY), reflecting weaker profitability.
Analyst sentiment is mixed. Truist initiated a Buy rating with an $85 price target, while RBC Capital raised its target to $68. However, Barclays lowered its target to $70, and other analysts remain cautious about market risks and affordability challenges.
